Inhibition of STAT3Y705 phosphorylation by Stattic suppresses proliferation and induces mitochondrial-dependent apoptosis in pancreatic cancer cells
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of STAT3Y705 phosphorylation by Stattic suppresses proliferation and induces mitochondrial-dependent apoptosis in pancreatic cancer cells
Authors
Keywords
-
Journal
Cell Death Discovery
Volume 8, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-03-15
DOI
10.1038/s41420-022-00922-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting STAT3 by a small molecule suppresses pancreatic cancer progression
- (2021) Huang Chen et al. ONCOGENE
- Broadening horizons: the role of ferroptosis in cancer
- (2021) Xin Chen et al. Nature Reviews Clinical Oncology
- Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression
- (2020) Kaitao Yuan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Ferroptosis in Cancer Cell Biology
- (2020) Christina M. Bebber et al. Cancers
- Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
- (2020) Uddalak Bharadwaj et al. PHARMACOLOGICAL REVIEWS
- IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis
- (2020) Rasmus Siersbæk et al. CANCER CELL
- Pancreatic cancer
- (2020) Jonathan D Mizrahi et al. LANCET
- Regulation and modulation of antitumor immunity in pancreatic cancer
- (2020) Joshua Leinwand et al. NATURE IMMUNOLOGY
- Ferroptosis is a type of autophagy-dependent cell death
- (2019) Borong Zhou et al. SEMINARS IN CANCER BIOLOGY
- Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2/STAT3/VEGFA signaling in non-small cell lung cancer cells
- (2019) Lijun Liang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
- (2019) Lehe Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
- (2019) Jiang-Jiang Qin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Resveratrol suppresses the myofibroblastic phenotype and fibrosis formation in kidneys via proliferation‐related signalling pathways
- (2019) Xing Zhang et al. BRITISH JOURNAL OF PHARMACOLOGY
- ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer
- (2019) Shigeru Hashimoto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recent Progress in Ferroptosis Inducers for Cancer Therapy
- (2019) Chen Liang et al. ADVANCED MATERIALS
- Pancreatic Cancer
- (2019) Alexandra Moore et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Repurposing of drugs as STAT3 inhibitors for cancer therapy
- (2019) Pathum S. Thilakasiri et al. SEMINARS IN CANCER BIOLOGY
- STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma
- (2019) Carol Lee et al. Cancers
- Ferroptosis is a lysosomal cell death process
- (2018) Huan Gao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer
- (2018) Kun Fan et al. CANCER LETTERS
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma
- (2018) Janet E. Murphy et al. JAMA Oncology
- Advances in nanomaterial based optical biosensing and bioimaging of apoptosis via caspase-3 activity: a review
- (2018) Balal Khalilzadeh et al. MICROCHIMICA ACTA
- Tumor microenvironment participates in metastasis of pancreatic cancer
- (2018) Bo Ren et al. Molecular Cancer
- STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells
- (2018) Prajna Guha et al. ONCOGENE
- Optimizing the outcomes of pancreatic cancer surgery
- (2018) Oliver Strobel et al. Nature Reviews Clinical Oncology
- The JAK/STAT3 axis: A comprehensive drug target for solid malignancies
- (2017) Jennifer Huynh et al. SEMINARS IN CANCER BIOLOGY
- KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer
- (2017) Jonas Cicenas et al. Cancers
- Loss of P53 Function Activates JAK2–STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival
- (2016) Sonja M. Wörmann et al. GASTROENTEROLOGY
- YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK–STAT3 Signaling
- (2016) Ralph Gruber et al. GASTROENTEROLOGY
- STAT3 as a potential therapeutic target in ALDH+ and CD44+/CD24+ stem cell-like pancreatic cancer cells
- (2016) Li Lin et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancer
- (2016) N Stojanovic et al. ONCOGENE
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Cell Death
- (2009) Richard S. Hotchkiss et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now